Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.10.0.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2018
Significant Accounting Policies Tables  
Concentrations of credit risk

Revenues and accounts receivable are concentrated between two major payers with the approximate risk level outlined below.

 

Concentration of Risk
Revenue Concentration:                
      Three months ended September 30,
    2018   2017
Medicare     31.2 %     33.8 %
Commercial Payor 1     17.4 %     18.0 %
Commercial Payor 2           10.7 %
                 
      Nine Months ended September 30,
    2018   2017
Medicare     32.7 %     35.7 %
Commercial Payor 1     16.6 %     18.4 %
Commercial Payor 2           11.6 %
                 
Receivable Concentration:                
    September 30,   September 30, 
    2018   2017
Medicare     24.4 %     20.6 %
Commercial Payor 1           15.3 %
Commercial Payor 2     13.1 %     13.8 %

 

Net (loss) income per share

Diluted net income per common share is based on the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding and computed as follows:

 

    Three months ended
September 30,
  Nine months ended
September 30,
    2018   2017   2018   2017
Numerator:                                
Net (loss) income attributable to First Choice Healthcare Solutions, Inc.   $ (263,586 )   $ (440,398 )   $ 447,301     $ (369,454 )
                                 
Denominator:                                
Weighted-average common shares, basic     32,490,673       26,765,021       31,174,347       26,622,335  
Weighted-average common shares, diluted     33,490,673       26,765,021       31,974,347       26,622,335  
                                 
Basic:   $ (0.01 )   $ (0.02 )   $ 0.01     $ (0.01 )
Diluted:   $ (0.01 )   $ (0.02 )   $ 0.01     $ (0.01 )

 

Potentially dilutive securities excluded from the basic and diluted net income (loss) per share are as follows:

 

    Three months ended
September 30,
  Nine months ended
September 30,
    2018   2017   2018   2017
Convertible line of credit     800,000       800,000             800,000  
Warrants to purchase common stock     1,875,000       1,875,000       1,875,000       1,875,000  
Options to purchase common stock     3,000,000       3,000,000       3,000,000       3,000,000  
Restricted stock awards     1,201,910       510,000       1,201,910       510,000  
      6,876,910       6,185,000       6,076,910       6,185,000